Bank of New York Mellon’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,338
| Closed | -$120K | – | 4220 |
|
|
2025
Q1 | $120K | Buy |
12,338
+1,070
| +9% | +$10.4K | ﹤0.01% | 3959 |
|
|
2024
Q4 | $142K | Sell |
11,268
-8
| -0.1% | -$101 | ﹤0.01% | 3981 |
|
|
2024
Q3 | $181K | Sell |
11,276
-3,048
| -21% | -$49K | ﹤0.01% | 3927 |
|
|
2024
Q2 | $349K | Buy |
14,324
+2,772
| +24% | +$67.6K | ﹤0.01% | 3741 |
|
|
2024
Q1 | $830K | Sell |
11,552
-1,176
| -9% | -$84.5K | ﹤0.01% | 3243 |
|
|
2023
Q4 | $2.53M | Buy |
12,728
+905
| +8% | +$180K | ﹤0.01% | 2712 |
|
|
2023
Q3 | $1.57M | Buy |
11,823
+2
| +0% | +$266 | ﹤0.01% | 2937 |
|
|
2023
Q2 | $1.77M | Buy |
11,821
+203
| +2% | +$30.4K | ﹤0.01% | 2911 |
|
|
2023
Q1 | $1.71M | Buy |
11,618
+1,315
| +13% | +$193K | ﹤0.01% | 2887 |
|
|
2022
Q4 | $1.63M | Buy |
10,303
+221
| +2% | +$35K | ﹤0.01% | 2950 |
|
|
2022
Q3 | $1.94M | Buy |
10,082
+1,086
| +12% | +$209K | ﹤0.01% | 2875 |
|
|
2022
Q2 | $1.31M | Buy |
8,996
+773
| +9% | +$113K | ﹤0.01% | 3067 |
|
|
2022
Q1 | $1.45M | Sell |
8,223
-23
| -0.3% | -$4.05K | ﹤0.01% | 3103 |
|
|
2021
Q4 | $2.42M | Sell |
8,246
-2,345
| -22% | -$689K | ﹤0.01% | 2880 |
|
|
2021
Q3 | $2.63M | Buy |
10,591
+1,705
| +19% | +$424K | ﹤0.01% | 2833 |
|
|
2021
Q2 | $2.26M | Buy |
8,886
+3,110
| +54% | +$791K | ﹤0.01% | 2904 |
|
|
2021
Q1 | $1.03M | Sell |
5,776
-71
| -1% | -$12.6K | ﹤0.01% | 3314 |
|
|
2020
Q4 | $925K | Buy |
5,847
+2,128
| +57% | +$337K | ﹤0.01% | 3289 |
|
|
2020
Q3 | $958K | Buy |
3,719
+32
| +0.9% | +$8.24K | ﹤0.01% | 3151 |
|
|
2020
Q2 | $855K | Buy |
+3,687
| New | +$855K | ﹤0.01% | 3194 |
|